Ardelyx, Inc. (ARDX) stock analysis

In our weekly check, Ardelyx, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 10 pass, warnings: 2, red flags: 10.

Sector: Healthcare · Biotechnology

Strengths

• Margins rising

Warning signs

• High debt
• Weak interest cover
• Weak EPS growth
• Thin margins
• Weak free cash flow

Next earnings report: 2026-10-29

Similar companies

ANL · SGP · AVBP · SANA · ANRO · ACHV

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis